ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-10 09:28 am Sale | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -2,768,840![]() (Position Closed) | Filing |
2021-01-29 4:12 pm Purchase | 2021-01-19 | 13G | Jounce Therapeutics, Inc. JNCE | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,768,840 6.950% | 2,768,840![]() (New Position) | Filing |